The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors

Penumbra Inc.

Related Interviews

Drugmaker Ascendis Offers Proven Science and Commercial Upside
February 05, 2026
Warner, Jay

Penumbra and AngioDynamics Among Top Med-Tech Sector Picks
April 29, 2025
Lichtman, Steven M.

Ophthalmology Offers Attractive Opportunities for Medtech Investors
June 21, 2024
Zimmerman, Ryan

Lagging Medtech Sector Bounces Back with Strong First Quarter
June 08, 2023
Zimmerman, Ryan

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
GE Aerospace (General Electric Company)
Walmart Inc.
IBM (International Business Machines Corp.)
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Marcus & Millichap (MMI) CEO Hessam Nadji on 2025 Recovery and Strategic Growth
Global Net Lease (GNL) CEO Michael Weil on Strategic Deleveraging and 2026 Growth Outlook
Rand Capital CEO Daniel Penberthy on BDC Strategy and 2026 Growth Outlook
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Insurance Companies Provide Ballast in Tough Markets
Nintendo (NTDOY) 35% Upside: Why a $15B Cash Balance Protects Margins from Volatile Memory Pricing
Building an Active Bond ETF Strategy Around Volatility and Risk Control
ANALYST INTERVIEWS
Navigating BDC Credit Risk: Why KBW is Bullish on ARCC and GBDC Despite Sector Headwinds
REITs as a Safe Haven: Why Geopolitical Risk Could Drive 2026 Outperformance
NMRK Outlook: Why KBW Names Newmark a Top Pick for 2026 Recovery
Since 1963
© The Wall Street Transcript 2016, 2026
Terms and Conditions
Privacy Policy